{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T17:07:17Z","timestamp":1723828037289},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,27]]},"DOI":"10.7759\/cureus.47787","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:40:07Z","timestamp":1698403207000},"source":"Crossref","is-referenced-by-count":1,"title":["Bilateral Pheochromocytoma and Paraganglioma Tumors Due to Von Hippel-Lindau Syndrome in a 15-Year-Old Boy: A Case Report"],"prefix":"10.7759","author":[{"given":"Saeed","family":"Khalaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan F","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra S","family":"Alawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Alsaeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete O","year":"2022","unstructured":"Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol. 2022, 33:90-114. 10.1007\/s12022-022-09704-6","journal-title":"Endocr Pathol"},{"key":"ref2","article-title":"Hereditary Paraganglioma-Pheochromocytoma Syndromes","author":"Else T","year":"1993","unstructured":"Else T, Greenberg S, Fishbein L. Hereditary Paraganglioma-Pheochromocytoma Syndromes. Adam MP (ed): Washington; 1993."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1515\/enr-2017-0018","article-title":"Pheochromocytoma, diagnosis and treatment: review of the literature","volume":"51","author":"Farrugia FA","year":"2017","unstructured":"Farrugia FA, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos E, Zavras N, Sotiropoulos D. Pheochromocytoma, diagnosis and treatment: review of the literature. Endocr Regul. 2017, 51:168-81. 10.1515\/enr-2017-0018","journal-title":"Endocr Regul"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0321","article-title":"Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center","volume":"7","author":"Falhammar H","year":"2018","unstructured":"Falhammar H, Kjellman M, Calissendorff J. Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr Connect. 2018, 7:186-92. 10.1530\/EC-17-0321","journal-title":"Endocr Connect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14222","article-title":"Bilateral pheochromocytoma: clinical characteristics, treatment and longitudinal follow-up","volume":"93","author":"Kittah NE","year":"2020","unstructured":"Kittah NE, Gruber LM, Bancos I, et al.. Bilateral pheochromocytoma: clinical characteristics, treatment and longitudinal follow-up. Clin Endocrinol (Oxf). 2020, 93:288-95. 10.1111\/cen.14222","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0170","article-title":"Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas","volume":"18","author":"Welander J","year":"2011","unstructured":"Welander J, S\u00f6derkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011, 18:R253-76. 10.1530\/ERC-11-0170","journal-title":"Endocr Relat Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.15586\/jkcvhl.2017.88","article-title":"A review of Von Hippel-Lindau syndrome","volume":"4","author":"Varshney N","year":"2017","unstructured":"Varshney N, Kebede AA, Owusu-Dapaah H, Lather J, Kaushik M, Bhullar JS. A review of Von Hippel-Lindau syndrome. J Kidney Cancer VHL. 2017, 4:20-9. 10.15586\/jkcvhl.2017.88","journal-title":"J Kidney Cancer VHL"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0004563217739931","article-title":"Clinical evaluation and treatment of phaeochromocytoma","volume":"55","author":"Davison AS","year":"2018","unstructured":"Davison AS, Jones DM, Ruthven S, Helliwell T, Shore SL. Clinical evaluation and treatment of phaeochromocytoma. Ann Clin Biochem. 2018, 55:34-48. 10.1177\/0004563217739931","journal-title":"Ann Clin Biochem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-021-02622-9","article-title":"Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas","volume":"23","author":"Garcia-Carbonero R","year":"2021","unstructured":"Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, et al.. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin Transl Oncol. 2021, 23:1995-2019. 10.1007\/s12094-021-02622-9","journal-title":"Clin Transl Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259689","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"62","author":"Carrasquillo JA","year":"2021","unstructured":"Carrasquillo JA, Chen CC, Jha A, Ling A, Lin FI, Pryma DA, Pacak K. Imaging of pheochromocytoma and paraganglioma. J Nucl Med. 2021, 62:1033-42. 10.2967\/jnumed.120.259689","journal-title":"J Nucl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-010-0151-1","article-title":"Genetic testing for pheochromocytoma","volume":"12","author":"Karasek D","year":"2010","unstructured":"Karasek D, Frysak Z, Pacak K. Genetic testing for pheochromocytoma. Curr Hypertens Rep. 2010, 12:456-64. 10.1007\/s11906-010-0151-1","journal-title":"Curr Hypertens Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock M","year":"2020","unstructured":"Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, Stewart PM. Adrenal incidentaloma. Endocr Rev. 2020, 41:775-820. 10.1210\/endrev\/bnaa008","journal-title":"Endocr Rev"},{"key":"ref13","article-title":"Incidental adrenal masses - a primary care approach","volume":"46","author":"Gendy R","year":"2017","unstructured":"Gendy R, Rashid P. Incidental adrenal masses - a primary care approach. Aust Fam Physician. 2017, 46:385-90.","journal-title":"Aust Fam Physician"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7969","article-title":"Pheochromocytoma and paraganglioma: a review of diagnosis, management and treatment of rare causes of hypertension","volume":"12","author":"Cerqueira A","year":"2020","unstructured":"Cerqueira A, Seco T, Costa A, Tavares M, Cotter J. Pheochromocytoma and paraganglioma: a review of diagnosis, management and treatment of rare causes of hypertension. Cureus. 2020, 12:e7969. 10.7759\/cureus.7969","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.86976","article-title":"Medical management of pheochromocytoma: role of the endocrinologist","volume":"15 Suppl 4","author":"Garg MK","year":"2011","unstructured":"Garg MK, Kharb S, Brar KS, Gundgurthi A, Mittal R. Medical management of pheochromocytoma: role of the endocrinologist. Indian J Endocrinol Metab. 2011, 15 Suppl 4:S329-36. 10.4103\/2230-8210.86976","journal-title":"Indian J Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin PF","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM, et al.. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016, 174:G1-G10. 10.1530\/EJE-16-0033","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.10.25","article-title":"Pheochromocytoma\/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options","volume":"9","author":"Antonio K","year":"2020","unstructured":"Antonio K, Valdez MM, Mercado-Asis L, Ta\u00efeb D, Pacak K. Pheochromocytoma\/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options. Gland Surg. 2020, 9:105-23. 10.21037\/gs.2019.10.25","journal-title":"Gland Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/199263-bilateral-pheochromocytoma-and-paraganglioma-tumors-due-to-von-hippel-lindau-syndrome-in-a-15-year-old-boy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:59Z","timestamp":1707509279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/199263-bilateral-pheochromocytoma-and-paraganglioma-tumors-due-to-von-hippel-lindau-syndrome-in-a-15-year-old-boy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.47787","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,27]]}}}